Cargando…

Lipid and protein oxidation in female patients with chronic fatigue syndrome

INTRODUCTION: Chronic fatigue syndrome (CFS) is a widely recognized problem, characterized by prolonged, debilitating fatigue and a characteristic group of accompanying symptoms, that occurs four times more frequently in women than in men. The aim of the study was to determine the existence of oxida...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomic, Slavica, Brkic, Snezana, Maric, Daniela, Mikic, Aleksandra Novakov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506242/
https://www.ncbi.nlm.nih.gov/pubmed/23185200
http://dx.doi.org/10.5114/aoms.2012.31620
_version_ 1782250874598326272
author Tomic, Slavica
Brkic, Snezana
Maric, Daniela
Mikic, Aleksandra Novakov
author_facet Tomic, Slavica
Brkic, Snezana
Maric, Daniela
Mikic, Aleksandra Novakov
author_sort Tomic, Slavica
collection PubMed
description INTRODUCTION: Chronic fatigue syndrome (CFS) is a widely recognized problem, characterized by prolonged, debilitating fatigue and a characteristic group of accompanying symptoms, that occurs four times more frequently in women than in men. The aim of the study was to determine the existence of oxidative stress and its possible consequences in female patients with CFS. MATERIAL AND METHODS: Twenty-four women aged 15-45 who fulfilled the diagnostic criteria for CFS with no comorbidities were recruited and were age matched to a control group of 19 healthy women. After conducting the routine laboratory tests, levels of the lipid oxidation product malondialdehyde (MDA) and protein oxidation protein carbonyl (CO) were determined. RESULTS: The CFS group had higher levels of triglycerides (p = 0.03), MDA (p = 0.03) and CO (p = 0.002) and lower levels of HDL cholesterol (p = 0.001) than the control group. There were no significant differences in the levels of total protein, total cholesterol or LDL cholesterol. CONCLUSIONS: The CFS group had an unfavorable lipid profile and signs of oxidative stress induced damage to lipids and proteins. These results might be indicative of early proatherogenic processes in this group of patients who are otherwise at low risk for atherosclerosis. Antioxidant treatment and life style changes are indicated for women with CFS, as well as closer observation in order to assess the degree of atherosclerosis.
format Online
Article
Text
id pubmed-3506242
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-35062422012-11-26 Lipid and protein oxidation in female patients with chronic fatigue syndrome Tomic, Slavica Brkic, Snezana Maric, Daniela Mikic, Aleksandra Novakov Arch Med Sci Clinical Research INTRODUCTION: Chronic fatigue syndrome (CFS) is a widely recognized problem, characterized by prolonged, debilitating fatigue and a characteristic group of accompanying symptoms, that occurs four times more frequently in women than in men. The aim of the study was to determine the existence of oxidative stress and its possible consequences in female patients with CFS. MATERIAL AND METHODS: Twenty-four women aged 15-45 who fulfilled the diagnostic criteria for CFS with no comorbidities were recruited and were age matched to a control group of 19 healthy women. After conducting the routine laboratory tests, levels of the lipid oxidation product malondialdehyde (MDA) and protein oxidation protein carbonyl (CO) were determined. RESULTS: The CFS group had higher levels of triglycerides (p = 0.03), MDA (p = 0.03) and CO (p = 0.002) and lower levels of HDL cholesterol (p = 0.001) than the control group. There were no significant differences in the levels of total protein, total cholesterol or LDL cholesterol. CONCLUSIONS: The CFS group had an unfavorable lipid profile and signs of oxidative stress induced damage to lipids and proteins. These results might be indicative of early proatherogenic processes in this group of patients who are otherwise at low risk for atherosclerosis. Antioxidant treatment and life style changes are indicated for women with CFS, as well as closer observation in order to assess the degree of atherosclerosis. Termedia Publishing House 2012-11-07 2012-11-09 /pmc/articles/PMC3506242/ /pubmed/23185200 http://dx.doi.org/10.5114/aoms.2012.31620 Text en Copyright © 2012 Termedia & Banach http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research
Tomic, Slavica
Brkic, Snezana
Maric, Daniela
Mikic, Aleksandra Novakov
Lipid and protein oxidation in female patients with chronic fatigue syndrome
title Lipid and protein oxidation in female patients with chronic fatigue syndrome
title_full Lipid and protein oxidation in female patients with chronic fatigue syndrome
title_fullStr Lipid and protein oxidation in female patients with chronic fatigue syndrome
title_full_unstemmed Lipid and protein oxidation in female patients with chronic fatigue syndrome
title_short Lipid and protein oxidation in female patients with chronic fatigue syndrome
title_sort lipid and protein oxidation in female patients with chronic fatigue syndrome
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506242/
https://www.ncbi.nlm.nih.gov/pubmed/23185200
http://dx.doi.org/10.5114/aoms.2012.31620
work_keys_str_mv AT tomicslavica lipidandproteinoxidationinfemalepatientswithchronicfatiguesyndrome
AT brkicsnezana lipidandproteinoxidationinfemalepatientswithchronicfatiguesyndrome
AT maricdaniela lipidandproteinoxidationinfemalepatientswithchronicfatiguesyndrome
AT mikicaleksandranovakov lipidandproteinoxidationinfemalepatientswithchronicfatiguesyndrome